gms | German Medical Science

73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

29.05. - 01.06.2022, Köln

Vorträge Dienstag, 31.05.2022
Experimentelle Neuroonkologie II/Experimental neurooncology II

Meeting Abstract (V143)

Prevalence of M2c macrophages in newly diagnosed glioblastoma correlates with an exhausted PD-1+/Tim-3+ effector memory T-cell phenotype with low IFNg-production

Kuballa M, Datsi A, Rapp M, Knobbe-Thomsen C, Sabel M, Sorg RV
[Full Text]
Meeting Abstract (V144)

The effect of a novel Aurora-A kinase inhibitor in combination with tumour treating fields and temozolomide on glioblastoma cells

Novikova K, Michen S, Robel K, Temme A, Krex D
[Full Text]
Meeting Abstract (V145)

Tumour Treating Fields (TTFields) promotes Rho kinase-dependent phosphorylation of the tight junction protein claudin-5

Salvador E, Keßler AF, Burek M, Tempel Brami C, Voloshin-Sela T, Volodin A, Adel Z, Giladi M, Ernestus RI, Löhr M, Förster C, Hagemann C
[Full Text]
Meeting Abstract (V146)

Electrical signaling is essential for dynamic transcriptional plasticity in Glioblastoma

Joseph K, Vollmer L, Ravi VM, Beck J, Hofmann U, Schnell O, Heiland DH
[Full Text]
Meeting Abstract (V147)

Combined treatment with ONC201/TIC10 and ABT-263 results in a synergistic anti-medulloblastoma activity in vitro

Spilz A, Dwucet A, Seyfried F, Peraud A, Prabhu VV, Allen JE, Westhoff MA, Siegelin MD, Wirtz CR, Karpel-Massler G
[Full Text]
Meeting Abstract (V148)

Evaluation of 3-L- and 3-D-[18F] Fluorophenylalanines as PET tracers for tumour imaging

Timmer M, Krämer F, Gröner B, Hoffmann C, Craig A, Brugger M, Drzezga A, Neumaier F, Zlatopolskiy B, Endepols H, Neumaier B
[Full Text]